Alison Moore, the President and CEO of Codexis, Inc., recently sold 6,335 shares of the company’s stock. This transaction, reported in a filing with the SEC, was executed to satisfy tax obligations related to the vesting of restricted stock units (RSUs).
This sale is significant as it showcases the ongoing management activity within Codexis, a company that operates in the industrial organic chemicals sector. Such transactions are common among executives who receive compensation in the form of equity, particularly when they need to manage personal tax liabilities.
Background
Codexis, Inc. is a prominent player in the industrial organic chemicals industry, focusing on the development and commercialization of enzyme-based solutions. The company is headquartered in Redwood City, California, and trades under the ticker symbol CDXS. Its recent filings include a Form 4 submitted on October 14, 2026, and a Form 144 filed just a day prior on October 13, 2026.
What the Filing Says
The recent SEC filing indicates that the transaction took place on October 12, 2026, with a price per share of $1.3606. The filing notes, "The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units (RSUs) of the Issuer." Following this transaction, Moore retains ownership of 244,171 shares, which includes 119,582 restricted stock units.
Impact
This sale may have implications for Codexis as it reflects the company's ongoing executive compensation strategies and tax management practices. It also highlights the importance of transparency in executive transactions, which can influence investor perception and market confidence.
What's Next
The filing does not say what happens next.